Results 271 to 280 of about 154,772 (354)

Insights Into Macrophage Ferroptosis: Implications for Atherosclerosis

Cell Proliferation, EarlyView.
Macrophage ferroptosis drives atherosclerosis by enhancing oxidative stress and inflammation, accelerating plaque progression and instability. Targeting macrophage ferroptosis presents a promising therapeutic strategy for atherosclerosis treatment.
Xiehui Chen, Xiangbo Liu, Changchun Zeng
wiley   +1 more source

LncRNA SCARNA8 promotes atherosclerotic plaque instability by inhibiting macrophage efferocytosis. [PDF]

Epigenetics
Yin X, Chen X, Wang T, Yang J, Yu J, Yang J.   +5 more
europepmc   +1 more source

Human atherosclerotic plaque macrophages associate with clinical presentation and follow diverse lineage differentiation routes [PDF]

Koen H.M. Prange, Gemma Bel-Bordes, Marie A.C. Depuydt, Rosalie W.M. Kempkes, M D M De Jong, Barend M. Mol, B Slutter, Ilze Bot, Annette E. Neele, Dominique P.V. de Kleijn, Gert J. de Borst, Johan Kuiper, Gerard Pasterkamp, Michal Mokrý, Menno P.J. de Winther   +14 more
openalex   +1 more source

Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER)

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess the real‐world effectiveness of semaglutide versus tirzepatide in reducing major adverse cardiovascular events (MACE) among patients with overweight/obesity and established atherosclerotic cardiovascular disease (ASCVD) without diabetes in an insured US population.
Lauren Wilson, Zhenxiang Zhao, Victoria Divino, Matthew Bassan, Bríain Ó. Hartaigh, Signe Stensen, Kerem Ozer   +6 more
wiley   +1 more source

Tanyu Tongzhi Formula relieves the progression of atherosclerotic plaque through lipid regulation and anti-inflammatory effects. [PDF]

Front Cardiovasc Med
Chen T, Xie L, Zhao Y, Wu L, Huang S, Mao W.   +5 more
europepmc   +1 more source

Effect of Monosodium Urate Crystal Deposition on Atherosclerotic Carotid Plaques [PDF]

Daina Kashiwazaki, Kunitaka Maruyama, Saori Hamada, Shusuke Yamamoto, Emiko Hori, Naoki Akioka, Kyo Noguchi, Satoshi Kuroda   +7 more
openalex   +1 more source

Polycythemia Vera and Essential Thrombocythemia: A Nationwide Population‐Based Study on Treatment Patterns, Vascular Complications and Survival

European Journal of Haematology, EarlyView.
ABSTRACT Background Polycythemia vera (PV) and essential thrombocythemia (ET) are associated with a well‐recognized increased risk of thrombotic events, bleeding, and all‐cause mortality, but the frequency of these outcomes during treatment has rarely been assessed in large cohorts.
Anneli Enblom Larsson, Henrik Renlund, Björn Andréasson, Henrik Holmberg, Maria Liljeholm, Anders Själander   +5 more
wiley   +1 more source

In vivo quantitative assessment of atherosclerotic plaque: A validation study on the optical coherence tomography-derived index of plaque attenuation. [PDF]

Medicine (Baltimore)
Cai X, Cao Y, Lu Q, Jing J, Wei K, Hu Y, Wang M, Zhou S, Chen Y.   +8 more
europepmc   +1 more source

Seizure recurrence after GLP‐1 receptor agonist initiation in adults with epilepsy

Epilepsia, EarlyView.
Abstract Objective To examine whether initiation of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) is associated with seizure recurrence and related outcomes in adults with epilepsy and type 2 diabetes. Methods We conducted a retrospective cohort study using de‐identified electronic health records from the TriNetX Research Network (January 2003 ...
Majd A. AbuAlrob, Abdullah Hussein, Rand Abdellatif, Adham Itbaisha, Khaled Zammar, Boulenouar Mesraoua   +5 more
wiley   +1 more source

Carotid Intima‐Media Thickness as a Marker of Subclinical Atherosclerosis in Adolescents With Severe Haemophilia

Haemophilia, EarlyView.
ABSTRACT Background The clinical focus of haemophilia has expanded beyond bleeding outcomes to encompass long‐term comorbidities such as cardiovascular disease (CVD). However, it remains unclear when vascular changes begin in this population. Carotid intima‐media thickness (cIMT), a validated, non‐invasive marker of subclinical atherosclerosis, may ...
Alyson Trillo, Juanita Hunter, Audrey Ofir, Jamie Shoag, Joanna A. Davis, Fernando F. Corrales‐Medina   +5 more
wiley   +1 more source